LSE - Delayed Quote GBp
Oxford Nanopore Technologies plc (ONT.L)
127.70
+0.20
+(0.16%)
As of 1:23:33 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
183,191
183,191
169,668
198,603
133,661
Cost of Revenue
77,796
77,796
79,187
74,793
60,466
Gross Profit
105,395
105,395
90,481
123,810
73,195
Operating Expense
257,728
257,728
259,090
222,289
237,728
Operating Income
-152,333
-152,333
-168,609
-98,479
-164,533
Net Non Operating Interest Income Expense
11,276
11,276
16,647
4,313
-684
Pretax Income
-139,961
-139,961
-149,768
-83,411
-166,004
Tax Provision
6,227
6,227
4,739
7,614
1,609
Net Income Common Stockholders
-146,188
-146,188
-154,507
-91,025
-167,613
Diluted NI Available to Com Stockholders
-146,188
-146,188
-154,507
-91,025
-167,613
Basic EPS
-0.16
--
-0.19
-0.11
-0.23
Diluted EPS
-0.16
--
-0.19
-0.11
-0.23
Basic Average Shares
897,796.42
--
833,960.36
823,742.71
731,938.59
Diluted Average Shares
897,796.42
--
833,960.36
823,742.71
731,938.59
Total Operating Income as Reported
-152,333
-152,333
-168,609
-98,479
-164,533
Rent Expense Supplemental
971
971
928
602
180
Total Expenses
335,524
335,524
338,277
297,082
298,194
Net Income from Continuing & Discontinued Operation
-146,188
-146,188
-154,507
-91,025
-167,613
Normalized Income
-145,531.75
-145,531.75
-156,468.82
-99,929.33
-167,027.37
Interest Income
14,841
14,841
18,853
5,941
224
Interest Expense
3,565
3,565
2,206
1,628
908
Net Interest Income
11,276
11,276
16,647
4,313
-684
EBIT
-136,396
-136,396
-147,562
-81,783
-165,096
EBITDA
-93,112
-93,112
-105,935
-49,912
-140,405
Reconciled Cost of Revenue
77,796
77,796
79,187
74,793
60,466
Reconciled Depreciation
43,284
43,284
41,627
31,871
24,691
Net Income from Continuing Operation Net Minority Interest
-146,188
-146,188
-154,507
-91,025
-167,613
Total Unusual Items Excluding Goodwill
-875
-875
2,422
10,993
-723
Total Unusual Items
-875
-875
2,422
10,993
-723
Normalized EBITDA
-92,237
-92,237
-108,357
-60,905
-139,682
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-218.75
-218.75
460.18
2,088.67
-137.37
12/31/2021 - 9/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OXB.L Oxford Biomedica plc
296.81
+0.27%
HVO.L hVIVO plc
18.15
+0.14%
SCLP.L Scancell Holdings plc
9.11
-1.49%
AVCT.L Avacta Group Plc
32.63
-4.04%
EWTX Edgewise Therapeutics, Inc.
14.45
-0.69%
IDIA.SW Idorsia Ltd
1.3260
+1.38%
1AEA.BE argenx SE
500.00
0.00%
AREC.L Arecor Therapeutics plc
41.10
+0.24%
AZT.OL ArcticZymes Technologies ASA
16.65
+1.22%
DNLI Denali Therapeutics Inc.
14.16
+1.43%